{
    "title": "Novavax forecasts higher-than-expected revenue; shares surge",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12063543/Novavax-eases-doubts-future-job-cuts-COVID-flu-shot-data.html",
    "date": "2023-05-09",
    "keywords": [
        "vaccine",
        "covid",
        "revenue",
        "market",
        "company",
        "shot",
        "combination",
        "share",
        "bhanvi",
        "satija",
        "erman",
        "tuesday",
        "business",
        "government",
        "novavax",
        "fall",
        "cost",
        "year",
        "song",
        "booster",
        "marketplace",
        "loss",
        "reporting",
        "bengaluru",
        "maker",
        "inc",
        "street",
        "quarter",
        "workforce",
        "recovery",
        "biotech",
        "ability",
        "uncertainty",
        "arbitration",
        "alliance",
        "gavi",
        "lone",
        "product",
        "circulating",
        "drugmaker",
        "data",
        "purchase",
        "analyst",
        "roger",
        "amount",
        "surprise",
        "campaign",
        "version",
        "time",
        "covid19",
        "season",
        "messenger",
        "executive",
        "john",
        "jacobs",
        "companys",
        "strategy",
        "country",
        "pandemic",
        "health",
        "emergency",
        "follower",
        "interview",
        "bit",
        "job",
        "research",
        "cash",
        "quarterend",
        "dec",
        "aim",
        "midstage",
        "trial",
        "response",
        "michael",
        "york",
        "mahobe",
        "editing",
        "syamnath",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}